v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2025   133,938      
Beginning Balance, Amount at Apr. 30, 2025 $ 838,303 $ 133 $ 2,216,284 $ 521 $ (1,378,635)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)   266      
Issuance of Class A common stock upon exercise of stock options, net of repurchases 1,286   1,286    
Vesting of early exercised Class A common stock options 5   5    
Vesting of restricted stock units (in shares)   2,657      
Vesting of restricted stock units 22,041 $ 3 22,038    
Stock-based compensation expense 54,553   54,553    
Other comprehensive income (595)     (595)  
Net loss (116,769)       (116,769)
Ending Balance, shares (in shares) at Jul. 31, 2025   136,861      
Ending Balance, Amount at Jul. 31, 2025 798,824 $ 136 2,294,166 (74) (1,495,404)
Beginning Balance, shares (in shares) at Apr. 30, 2026   148,008      
Beginning Balance, Amount at Apr. 30, 2026 $ 653,751 $ 148 2,502,657 (50) (1,849,004)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares) 7,879 7,879      
Issuance of Class A common stock upon exercise of stock options, net of repurchases $ 72,807 $ 7 72,800    
Vesting of restricted stock units (in shares)   3,918      
Vesting of restricted stock units 19,273 $ 4 19,269    
Stock-based compensation expense 42,437   42,437    
Other comprehensive income (560)     (560)  
Net loss (92,812)       (92,812)
Ending Balance, shares (in shares) at Jul. 31, 2026   159,805      
Ending Balance, Amount at Jul. 31, 2026 $ 694,896 $ 159 $ 2,637,163 $ (610) $ (1,941,816)